Comments
Loading...

Cyclerion Therapeutics (CYCN) Stock Price, Quote, News & History

CYCNNASDAQ
Logo brought to you by Benzinga Data
$1.36
-0.16-10.53%
At close: Jan 15, 4:00 PM EST
$1.33
-0.03-2.21%
After Hours: 5:29 PM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
$1.49
Close
$1.36
Volume / Avg.
162.38K / 1.74M
Day Range
$1.36 - $1.51
52 Wk Range
1.16 - 6.25
Market Cap
$5.06M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
3.63%
Days to Cover
4.13

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-1.38M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
3.07M
Free Cash Flow (TTM)
-1.38M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
1.70M

Valuation Metrics

Enterprise Value
$1.22M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.52
PB Ratio (TTM)
0.61
Earnings Yield % (TTM)
-46.05%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.51

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$4.57M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.49
Close
$1.36
Volume / Avg.
162.38K / 1.74M
Day Range
$1.36 - $1.51
52 Wk Range
1.16 - 6.25
Market Cap
$5.06M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
3.63%
Days to Cover
4.13

About

Sector
Health Care
Industry
Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus i...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CYCN
ACXP

FAQ

Q

How do I buy Cyclerion Therapeutics (CYCN) stock?

A

You can purchase shares of Cyclerion Therapeutics (NASDAQ:CYCN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cyclerion Therapeutics (CYCN) competitors?

Q

What is the forecast, or price target, for Cyclerion Therapeutics (CYCN) stock?

A

There is no analysis for Cyclerion Therapeutics to provide a consensus price target.

Q

What is the current price for Cyclerion Therapeutics (CYCN)?

A

The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $1.33 last updated January 15, 2026 at 5:29 PM EST.

Q

Does Cyclerion Therapeutics (CYCN) pay a dividend?

A

There are no upcoming dividends for Cyclerion Therapeutics.

Q

When is Cyclerion Therapeutics (NASDAQ:CYCN) reporting earnings?

A

Cyclerion Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cyclerion Therapeutics (CYCN) going to split?

A

There is no upcoming split for Cyclerion Therapeutics.

Q

What sector and industry does Cyclerion Therapeutics (CYCN) operate in?

A

Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.